BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gulliver EL, Young RB, Chonwerawong M, D'Adamo GL, Thomason T, Widdop JT, Rutten EL, Rossetto Marcelino V, Bryant RV, Costello SP, O'Brien CL, Hold GL, Giles EM, Forster SC. Review article: the future of microbiome-based therapeutics. Aliment Pharmacol Ther 2022;56:192-208. [PMID: 35611465 DOI: 10.1111/apt.17049] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Choi Y, Han HS, Chong GO, Le TM, Nguyen HDT, Lee OE, Lee D, Seong WJ, Seo I, Cha HH. Updates on Group B Streptococcus Infection in the Field of Obstetrics and Gynecology. Microorganisms 2022;10. [PMID: 36557651 DOI: 10.3390/microorganisms10122398] [Reference Citation Analysis]
2 Fahey JW, Smilovitz Burak J, Evans D. Sprout microbial safety: A reappraisal after a quarter‐century. Food Frontiers 2022. [DOI: 10.1002/fft2.183] [Reference Citation Analysis]
3 Fabozzi G, Rebuzzini P, Cimadomo D, Allori M, Franzago M, Stuppia L, Garagna S, Ubaldi FM, Zuccotti M, Rienzi L. Endocrine-Disrupting Chemicals, Gut Microbiota, and Human (In)Fertility—It Is Time to Consider the Triad. Cells 2022;11:3335. [DOI: 10.3390/cells11213335] [Reference Citation Analysis]